SIME
SIME Diagnostics is a UK-based Medtech company revolutionizing acute respiratory care through its Clinical AI Platform. Founded in 2014, the company focuses on predicting respiratory diseases in critical care settings, particularly in neonatal and adult intensive care units. Their patented, compact point-of-care device utilizes AI technology to deliver rapid, accurate diagnostics, enabling early intervention and treatment for conditions like Respiratory Distress Syndrome and Chronic Lung Disease. With a mission to prevent acute respiratory diseases before symptoms develop, SIME aims to improve patient outcomes and reduce healthcare costs.
SIME
SIME Diagnostics is a UK-based Medtech company revolutionizing acute respiratory care through its Clinical AI Platform. Founded in 2014, the company focuses on predicting respiratory diseases in critical care settings, particularly in neonatal and adult intensive care units. Their patented, compact point-of-care device utilizes AI technology to deliver rapid, accurate diagnostics, enabling early intervention and treatment for conditions like Respiratory Distress Syndrome and Chronic Lung Disease. With a mission to prevent acute respiratory diseases before symptoms develop, SIME aims to improve patient outcomes and reduce healthcare costs.